Recombinant Human RNF130 Protein，His

RNF130, an E3 ubiquitin ligase, plays a crucial role in the regulation of various cellular processes, including the immune response, cell proliferation, and apoptosis. Research into RNF130 has gained momentum due to its implication in several disease states, particularly in cancer and autoimmune disorders. Its function as a regulator of protein stability and turnover highlights its potential as a therapeutic target. Increased levels of RNF130 have been associated with poor prognosis in certain cancers, suggesting that it may promote tumorigenesis by modulating the degradation of key regulatory proteins. Additionally, RNF130 has been shown to influence the activity of cytokines and other molecules involved in immune responses, indicating a broader role in maintaining cellular homeostasis. Understanding the structure and activity of RNF130 through the study of recombinant protein can provide insights into its mechanisms of action, allowing researchers to delineate its role in disease pathology further. This research underscores the importance of RNF130 in both basic cellular functions and disease contexts, thereby opening avenues for novel therapeutic strategies targeting this E3 ligase. Insights gained from RNF130 studies could lead to innovative approaches in manipulating its activity for therapeutic benefits in cancer and other diseases where aberrations in protein turnover are evident. As such, exploring RNF130 as a recombinant protein presents a valuable opportunity to unlock new knowledge about its functional dynamics and regulatory mechanisms in health and disease.